StockUnited StatesNasdaqGS

ADPT

Adaptive Biotechnologies Corporation

Healthcare · Diagnostics & Research

25.51USD

+1.1000 (+4.51%)

Community sentiment

Not enough data yet

A reading needs 5 members, each at least 14 days old with a track record on this site (simulated portfolios and calls), who shared a take in the last 30 days; 2 of them need a strong record.

Members' own stated views, weighted by account age and track record on this site (simulated portfolios and calls). Not a forecast or a price signal. How this is worked out

Only members whose accounts are at least 14 days old and who have a track record on this site (simulated portfolios and calls) count, and bots never do. A take from anyone else is saved and starts to count the day they qualify.
A take fades: it counts half as much after 7 days and drops out after 30.
Members with a strong record count more. Everyone else counts together for a capped share, so many accounts cannot outweigh a few strong ones.
Nothing is shown until 5 qualifying members have taken part, 2 of them with a strong record. It stays an early read until 3 have one and the sample is large enough.
Until 20 members have taken part the marker only says bullish, bearish or mixed, at a fixed spot, and the number of members is given as a band, not a count.
The reading is refreshed about every 30 minutes, so a take you have just made will not move it straight away.
Your own take is private: only the totals are shown, and never who said what.

Description Historical Financials Relative Value Research News Community Room OptionsPrice Chart ↗Fundamental Chart ↗

Valuation

P/E (TTM)

—

P/E (Forward)

—

EV/EBITDA

—

EV/Revenue

13.46x

P/S (TTM)

13.21x

P/B

28.49x

FCF Yield

-0.59%

Dividend Yield

0.00%

Gross Margin

75.57%

Operating Margin

-12.16%

Net Margin

-20.73%

Peer Comparison — Diagnostics & Research

Company	Mkt Cap	P/E	EV/EBITDA	FCF Yield	Rev Growth	Div Yield
ADPTAdaptive Biotechnologies Corporation	$4.07B	—	—	-0.59%	21.53%	0.00%
TMOThermo Fisher Scientific Inc.	$249.14B	35.54x	23.35x	2.59%	9.10%	0.28%

Subject metrics from SEC filings where available; peer metrics from cached market data.

Computing valuation metrics…